»á̾:ĹÅÄ͵Ƿ ¤Î¸¡º÷·ë²Ì / 1 1 - 8 / 8 <<< 1 >>> / 1 1 - 8 / 8 <<< 1 >>> 1E06-09 2023/03/14 13:00 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E Reveromycin AÀ¸¹çÀ®¹ÚÁÇRevK-RevLÊ£¹çÂÎ¥â¥Ç¥ë¹½Â¤¤Ë´ð¤Å¤¯RevLÊÑ°Û¹ÚÁǤβòÀϤÈÁê¸ßºîÍÑÎΰè¤Î·èÄê Analysis of RevL mutants based on model structure of RevK-RevL complex involved in reveromycin biosynthesis and determination of their interaction regions ¡û²¬Â¼ ±Ñ¼£1¡¢º´Æ£¡Ê¼®ùõ¡Ë ͵Èþ1¡¢±ü¼ ±ÑÉ×2¡¢·§ºä ¿ò2¡¢Ä¹ÅÄ ÍµÇ·1¡¢¹â¶¶ ½ÓÆó1 ¡ûEiji OKAMURA1, Yumi SATO-SHIOZAKI1, Hideo OKUMURA2, Takashi KUMASAKA2, Hiroyuki OSADA1, TAKAHASHI Shunji1 1Íý¸¦CSRS¡¢2¹âµ±ÅÙ¸÷²Ê³Ø¸¦µæ¥»¥ó¥¿¡¼ 1RIKEN CSRS, 2JASRI 1F02-03 2023/03/14 09:30 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à F OSMACË¡¤Ë¤è¤ê¸«½Ð¤µ¤ì¤¿ÊüÀþ¶ÝͳÍèÅ·Á³Êª¤ÎÀ¸¹çÀ®¸¦µæ Biosynthetic study on natural products from actinomycetes through an OSMAC methodology ¡û¾®ÎÓ Íµµ±1¡¢±óÆ£ ÎÆÂÀ1¡¢º´Æ£ Æ»Âç1¡¢Lopez Julius2¡¢ÌîÀî ½Óɧ2¡¢Ä¹ÅÄ ÍµÇ·1,2¡¢ÅÏÊÕ ¸Æó1 ¡ûYuki KOBAYASHI1, Ryota ENDO1, Michio SATO1, Julius LOPEZ2, Toshihiko NOGAWA2, Hiroyuki OSADA1,2, Kenji WATANABE1 1ÀŲ¬¸©Î©Âç³ØÌô¡¢2Íý¸¦´Ä¶»ñ¸»¥» 1Department of Pharmaceutical Sciences, University of Shizuoka, 2RIKEN 1F04-03 2023/03/14 10:30 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à F Furocoumarin·Ï²½¹çʪ£±¤ÎDHODHÆðÛŪÁ˳²µ¡¹½¤Î²òÌÀ Inhibition mechanism of furocoumarin–type compound 1 toward DHODH ¡ûÃ渶 ¼Â¶ê1¡¢ÅÏîµ Àµ¸ç1¡¢º´Æ£ Æ»Âç1¡¢±ü¼ ±ÑÉ×2¡¢Àîë À¿3¡¢Ä¹ÅÄ ÍµÇ·1,3¡¢ÅÏÊÕ ¸Æó1 ¡ûMIKU NAKAHARA1, Shogo Watanabe1, Michio Sato1, Hideo Okumura2, Makoto Kawatani3, Hiroyuki Osada1,3, Kenji Watanabe1 1ÀŲ¬¸©ÂçÌô¡¢2JASRI¡¢3Íý¸¦´Ä¶»ñ¸»¥» 1Dept. Pharm. Sci., Univ. Shizuoka, 2JASRI, 3RIKEN CSRS 2E01-03 2023/03/15 09:00 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E °äÅÁ»Ò²þÊÑ»å¾õ¶Ý¤è¤ê¼ý½¸¤·¤¿¥Ç¥«¥ê¥ó´Þͥƥȥé¥ß¥ó»À²½¹çʪ¤Î¹½Â¤³èÀÁê´Ø Structure-activity relationship of decalin-containing tetramic acids collected from genetically engineered fungi ¡û²ÃÆ£ ľ¼ù1,2¡¢ÌîÀî ½Óɧ2¡¢³¤Ï·¸¶ ²ÂÆà3¡¢Æó¼ ͧ»Ë2¡¢¾¾ÅÄ °ìɧ4¡¢Ã°±© δ²ð3¡¢¹â¶¶ ½ÓÆó2¡¢Ä¹ÅÄ ÍµÇ·2 ¡ûNaoki KATO1,2, Toshihiko NOGAWA2, Kana EBIHARA3, Yushi FUTAMURA2, Kazuhiko MATSUDA4, Ryusuke NIWA3, Shunji TAKAHASHI2, Hiroyuki OSADA2 1ÀÝÆîÂç¡¢2Íý¸¦CSRS¡¢3ÃÞÇÈÂç¡¢4¶áµ¦Âç 1Setsunan Univ., 2RIKEN CSRS, 3Univ. of Tsukuba, 4Kindai Univ. 2E08-01 2023/03/15 14:00 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E ¥«¥ó¥¸¥À¤ÎÆó·ÁÀ¤òÁ˳²¤¹¤ëSF2768¤ÎºîÍѵ¡½ø²òÀÏ Mode of action of SF2768, a modulator of Candida albicans dimorphism ¡ûÆó¼ ͧ»Ë1,2¡¢ÀÄÌî À²Èþ2¡¢»³ËÜ ¹ÃÈå2¡¢À¶¿å ÌÔ2¡¢¥¦¥½¥ó-¥í¥Ú¥¹ ¥ì¥¤¥Á¥§¥ë2¡¢ËÙ ¹¯¹¨2¡¢ÌÚÌî Ë®´ï1¡¢Ä¹ÅÄ ÍµÇ·1,2,3 ¡ûYushi FUTAMURA1,2, Harumi Aono2, Kai Yamamoto2, Takeshi Shimizu2, Rachael Uson-Lopez2, Yasuhiro Hori2, Kuniki Kino1, Hiroyuki Osada1,2,3 1Áá°ðÅÄÂç³Ø¡¢2Íý¸¦CSRS¡¢3ÀŲ¬¸©Î©Âç 1Waseda Univ., 2RIKEN CSRS, 3Univ. of Shizuoka 2E08-02 2023/03/15 14:00 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E ¹³¥«¥ó¥¸¥Àʪ¼ÁTPPB¤ÎºîÍѵ¡½ø²òÀÏ Mode of action of anti-Candida agent, TPPB ¡ûÀÄÌî À²Èþ1¡¢Æó¼ ͧ»Ë1,2¡¢ËÙ ¹¯¹¨1¡¢¼¼°æ À¿1¡¢Ê¿Ìî ¹°Ç·1¡¢À¾±º ÀµË§1¡¢¸ô ¾¤Ì±1¡¢ÌÚÌî Ë®´ï2¡¢Ä¹ÅÄ ÍµÇ·1,2,3 ¡ûHarumi AONO1, Yushi FUTAMURA1,2, Yasuhiro HORI1, Makoto MUROI1, Hiroyuki HIRANO1, Masayoshi NISHIURA1, Zhaomin HOU1, Kuniki KINO2, Hiroyuki OSADA1,2,3 1Íý¸¦ CSRS¡¢2Áá°ðÅÄÂç¡¢3ÀŲ¬¸©Î©Âç 1RIKEN CSRS, 2Waseda univ., 3Univ. of Shizuoka 2E08-03 2023/03/15 14:00 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E ¹í¶Ý¤Î·ÁÂÖÊѲ½¤ò»Øɸ¤È¤¹¤ëAI¶îÆ°·¿¹³¿¿¶ÝºÞ¥¹¥¯¥ê¡¼¥Ë¥ó¥°·Ï¤Î¹½ÃÛ Construction of Al-based screening system for antifungal substances based on morphological changes in Aspergillus oryzae ¡û±¬Ìî ¹¨¹¬1,2¡¢Æó¼ ͧ»Ë2,3¡¢Ä¹ÅÄ ÍµÇ·2,3,4¡¢ÌÚÌî Ë®´ï1,3 ¡ûHiroyuki UNO1,2, Yushi FUTAMURA2,3, Hiroyuki OSADA2,3,4, Kuniki KINO1,3 1ÁáÂ籡Àè¿ÊÍý¹©¡¢2Íý¸¦CSRS¡¢3ÁáÂçÍý¹©Áí¸¦¡¢4ÀŲ¬¸©ÂçÌô 1Sch. Adv. Sci. Eng., Waseda Univ., 2RIKEN CSRS, 3Res. Inst. Sci. Eng., Waseda Univ., 4Sch. Pha. Sci., Univ. of Shizuoka 2E08-12 2023/03/15 14:00 ¥ß¡¼¥Æ¥£¥ó¥°¥ë¡¼¥à E ·ì´ÉÆâÈéºÙ˦¤Ë¤ª¤±¤ëºÙ˦ÀÜÃå°ø»ÒICAM-1¤Îȯ¸½¤òÁ˳²¤¹¤ë²½¹çʪ¤Îõº÷ Screening of compounds that inhibit the expression of the cell adhesion molecule ICAM-1 in vascular endothelial cells ¡û²£ÅÄ Í¼²Â1¡¢ÇÏ¾ì ¹¯Êå1¡¢º´¡¹ÌÚ ºéµ¨1¡¢Àî¸ý ¹Ì°ìϺ1¡¢Ê¿Ìî ¹°Ç·2¡¢Ä¹ÅÄ ÍµÇ·2,3¡¢ÊÒ²¬ ¹§É×1 ¡ûYuka YOKOTA1, Kosuke BABA1, Saki SASAKI1, Koichiro KAWAGUCHI1, Hiroyuki HIRANO2, Hiroyuki OSADA2,3, Takao KATAOKA1 1µþÅÔ¹©·ÝÁ¡°ÝÂç³Ø¡¦±þÀ¸¡¢2Íý¸¦¡¦CSRS¡¢3ÀŲ¬¸©Â硦Ìô 1Dept. Appl. Biol., Kyoto Inst. Tech., 2RIKEN CSRS, 3Dept. Pharm. Sci., Univ. Shizuoka / 1 1 - 8 / 8 <<< 1 >>> / 1 1 - 8 / 8 <<< 1 >>>